This screen looks for one thing: a share price that has fallen over three months while both the analyst consensus and our own score stayed positive. It is a disagreement, not a verdict. Either the market has seen something the published views have not caught up with, or the views are right and the price overshot. The screen cannot tell you which — it tells you where to look, and shows the numbers that make each case.
Data as of 2026-11-09. 109 of 470 tracked IPOs qualify. Sorted by the three-month change, biggest fall first. The companion screen, where the price rose while the rating stayed cautious, runs the same test in the other direction.
Price fell, rating held
| what we compute | what you can get elsewhere too | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company | Our balance | Fundamentals | Flags | IPO | Market cap | Last | 3-month | Since IPO | Analyst index | Consensus | Target as of 2026-11-17 |
| WYFI | WhiteFiber, Inc. | Up +6 medium | loss-making -132.2% revenue +66.2% heavily indebted | Fell on sound metrics, Large daily move | 2025-08-07 | $427M | $6.35 | -68.9% | -42.2% | 0.2 | Strong Buy (11) | $31.45 +395% |
| UMAC | Unusual Machines, Inc. | Up +5 medium | loss-making -75.9% revenue +101.2% | — | 2024-02-14 | $586M | $8.64 | -62.6% | +238.2% | 0.3 | Strong Buy (9) | $30.11 +248% |
| BLZE | Backblaze, Inc. | Up +7 medium | loss-making -11.5% revenue +14.3% heavily indebted | Fell, analysts held, Improving confidence, Large daily move | 2021-11-11 | $489M | $6.44 | -60.1% | -56.7% | 1.5 | Buy (7) | $21.50 +234% |
| BCAX | Bicara Therapeutics Inc. | Up +8 medium | — | Fell, analysts held | 2024-09-13 | $665M | $8.44 | -59.8% | -49.0% | 0.7 | Buy (14) | $32.17 +281% |
| IREN | IREN Limited | Up +7 strong | loss-making -194.4% revenue +41.1% heavily indebted | Fell on sound metrics, Improving confidence | 2021-11-17 | $7.7B | $11.82 | -59.5% | -34.0% | 1.1 | Buy (20) | $56.69 +380% |
| CBRS | Cerebras Systems Inc. | Up +4 medium | loss-making -86.2% revenue +75.7% heavily indebted | Lock-up expiry, Fell on sound metrics, Large daily move | 2026-05-14 | $26.4B | $82.67 | -56.9% | -36.9% | 0.9 | Strong Buy (11) | $210.18 +154% |
| AESI | Atlas Energy Solutions Inc. | Leans up +3 medium | loss-making -13.0% revenue +3.7% heavily indebted | Fell, analysts held | 2023-03-09 | $698M | $4.98 | -56.5% | -52.9% | 1.0 | Buy (13) | $15.38 +209% |
| AVBP | ArriVent BioPharma, Inc. | Up +5 medium | — | Fell, analysts held | 2024-01-26 | $673M | $10.52 | -55.1% | -29.3% | 0.0 | Strong Buy (11) | $26.40 +151% |
| ITG | ITG, Inc. | Up +4 medium | loss-making -1.3% revenue +15.7% heavily indebted | Fell on sound metrics, Large daily move | 2026-07-01 | $705M | $5.53 | -54.2% | -52.6% | 0.0 | Strong Buy (9) | $11.33 +105% |
| CRDO | Credo Technology Group Holding Ltd | Up +9 strong | profitable 33.8% revenue +205.7% | — | 2022-01-27 | $24.7B | $99.86 | -53.5% | +2.1% | 0.0 | Strong Buy (20) | $277.47 +178% |
| EROC | ERock, Inc. | Up +5 medium | loss-making -2.9% revenue +42.5% heavily indebted | Fell on sound metrics | 2026-06-10 | $2.3B | $6.12 | -51.7% | -56.6% | 0.0 | Buy (8) | $18.88 +208% |
| LGN | Legence Corp. | Up +9 strong | profitable 1.0% revenue +21.5% heavily indebted | — | 2025-09-12 | $3.8B | $32.31 | -50.0% | +63.1% | 0.0 | Strong Buy (17) | $72.18 +123% |
| CRWV | CoreWeave, Inc. | Leans up +2 medium | loss-making -25.6% revenue +167.9% liquidity 0.4 heavily indebted | Thin liquidity | 2025-03-28 | $29.5B | $39.51 | -49.9% | +43.6% | 0.4 | Buy (41) | $115.34 +192% |
| CADL | Candel Therapeutics, Inc. | Up +8 medium | heavily indebted | Fell, analysts held, Improving confidence, Large daily move | 2021-07-27 | $486M | $5.04 | -49.0% | -28.1% | 1.1 | Strong Buy (10) | $17.67 +251% |
| INIO | Innio N.V. | Up +5 medium | profitable 2.7% revenue +22.1% heavily indebted | Lock-up expiry, Fell on sound metrics | 2026-06-04 | $10.9B | $12.07 | -48.2% | -35.7% | 0.5 | Buy (10) | $31.40 +160% |
| APMD | Apnimed, Inc. | Leans up +3 medium | revenue +380.1% | — | 2026-07-31 | $704M | $16.09 | -48.0% | +7.8% | 0.0 | Strong Buy (4) | $50.33 +213% |
| QNT | Quantinuum Inc. | Up +4 medium | loss-making -106.4% revenue +34.6% heavily indebted | Lock-up expiry, Fell on sound metrics | 2026-06-04 | $9.4B | $27.74 | -46.4% | -51.4% | 0.5 | Strong Buy (14) | $71.15 +156% |
| LIME | Neutron Holdings, Inc. | Up +7 strong | profitable 21.3% revenue +29.1% heavily indebted | — | 2026-07-01 | $1.3B | $19.37 | -46.1% | +3.4% | 0.0 | Strong Buy (8) | $33.14 +71% |
| RAPP | Rapport Therapeutics, Inc. | Up +5 medium | pre-revenue heavily indebted | — | 2024-06-07 | $1.6B | $23.16 | -46.0% | +58.2% | 0.1 | Strong Buy (16) | $64.21 +177% |
| ALHC | Alignment Healthcare, Inc. | Leans up +3 medium | profitable 0.6% revenue +46.1% heavily indebted | Weakening confidence | 2021-03-26 | $1.5B | $6.37 | -45.3% | — | -2.9 | Buy (15) | $10.79 +69% |
| NNE | NANO Nuclear Energy Inc. | Up +4 medium | pre-revenue | — | 2024-05-08 | $597M | $9.10 | -43.3% | +174.0% | -0.3 | Buy (9) | $34.75 +282% |
| FPS | Forgent Power Solutions, Inc. | Up +7 strong | profitable 7.4% revenue +88.5% heavily indebted | — | 2026-02-05 | $6.7B | $18.00 | -43.0% | +3.3% | 0.1 | Strong Buy (13) | $42.85 +138% |
| AVR | Anteris Technologies Global Corp. | Leans up +2 split | pre-revenue heavily indebted | Shrinking revenue, Large daily move | 2024-12-13 | $528M | $4.99 | -42.5% | -8.2% | -0.8 | Strong Buy (5) | $13.75 +176% |
| HMH | HMH Holding Inc. | Leans up +2 medium | loss-making -1.3% revenue -2.6% heavily indebted | Downgrade | 2026-04-01 | $542M | $10.98 | -42.0% | -2.1% | -0.5 | Strong Buy (7) | $22.43 +104% |
| CLYM | Climb Bio, Inc. | Leans up +3 medium | — | — | 2021-08-10 | $609M | $9.19 | -40.6% | -21.6% | -0.2 | Strong Buy (16) | $28.40 +209% |
| OMDA | Omada Health, Inc. | Up +7 strong | profitable 4.2% revenue +53.2% | — | 2025-06-06 | $889M | $11.87 | -39.7% | -10.8% | -0.1 | Buy (12) | $26.50 +123% |
| GLUE | Monte Rosa Therapeutics, Inc. | Up +10 strong | loss-making -186.2% revenue +63.5% heavily indebted | Fell on sound metrics | 2021-06-24 | $801M | $8.64 | -39.1% | -50.4% | 0.3 | Strong Buy (10) | $25.38 +194% |
| AVEX | AEVEX Corp. | Up +4 medium | profitable 3.6% revenue +10.4% heavily indebted | Lock-up expiry, Fell on sound metrics, Large daily move | 2026-04-17 | $1.6B | $11.04 | -38.1% | -29.3% | -0.3 | Buy (10) | $25.44 +130% |
| FRVO | Fervo Energy Company | Leans up +3 split | pre-revenue heavily indebted | Lock-up expiry, Fell, analysts held, Shrinking revenue, Improving confidence | 2026-05-13 | $3.4B | $9.99 | -36.4% | -61.0% | 8.1 | Strong Buy (16) | $29.47 +195% |
| IE | Ivanhoe Electric Inc. | Leans up +2 split | pre-revenue heavily indebted | Fell, analysts held | 2022-06-28 | $1.1B | $5.40 | -36.3% | -42.7% | 0.0 | Buy (7) | $20.58 +281% |
| DOCN | DigitalOcean Holdings, Inc. | Up +8 strong | profitable 3.1% revenue +15.5% heavily indebted | Improving confidence | 2021-03-24 | $10.2B | $66.76 | -36.2% | — | 1.6 | Strong Buy (17) | $159.93 +140% |
| MPLT | MapLight Therapeutics, Inc. | Up +4 medium | — | — | 2025-10-27 | $403M | $5.94 | -35.5% | -58.3% | -1.1 | Strong Buy (15) | $26.54 +347% |
| KRMN | Karman Holdings Inc. | Up +7 strong | profitable 7.5% revenue +36.6% heavily indebted | Improving confidence | 2025-02-13 | $5.4B | $29.25 | -34.2% | +58.6% | 1.8 | Strong Buy (14) | $67.00 +129% |
| DPC | DPC Holdings PLC | Up +7 strong | loss-making -16.8% revenue +12.2% heavily indebted | — | 2026-06-25 | $5.1B | $30.74 | -33.4% | +4.4% | -0.3 | Buy (5) | $52.20 +70% |
| ATTO | Attovia Therapeutics, Inc. | Up +5 medium | pre-revenue | — | 2026-08-05 | $691M | $15.10 | -33.4% | -12.3% | 0.5 | Strong Buy (5) | $43.20 +186% |
| AKTS | Aktis Oncology, Inc. | Up +7 strong | pre-revenue revenue +336.9% heavily indebted | — | 2026-01-09 | $927M | $16.15 | -32.8% | -14.8% | 0.3 | Strong Buy (10) | $35.88 +122% |
| KARD | Kardigan, Inc. | Up +6 medium | heavily indebted | — | 2026-06-18 | $1.3B | $11.54 | -32.8% | -20.9% | 0.7 | Strong Buy (9) | $41.00 +255% |
| KGS | Kodiak Gas Services, Inc. | Up +6 strong | profitable 11.3% revenue +12.8% heavily indebted | — | 2023-06-29 | $4.5B | $39.67 | -32.4% | +198.0% | 0.0 | Strong Buy (15) | $72.64 +83% |
| CTNM | Contineum Therapeutics, Inc. | Leans up +2 medium | heavily indebted | — | 2024-04-05 | $387M | $8.68 | -32.1% | -38.1% | -1.0 | Buy (8) | $21.43 +147% |
| WRD | WeRide Inc. | Up +4 medium | loss-making -199.0% revenue +89.6% heavily indebted | — | 2024-10-25 | $1.4B | $2.99 | -31.9% | -74.4% | -0.8 | Strong Buy (13) | $12.30 +312% |
| IMMX | Immix Biopharma, Inc. | Up +6 medium | — | — | 2021-12-16 | $657M | $6.96 | -30.9% | +41.2% | 0.4 | Strong Buy (7) | $23.80 +242% |
| ALAB | Astera Labs, Inc. | Up +6 strong | profitable 29.6% revenue +115.1% | — | 2024-03-20 | $38.8B | $180.35 | -30.7% | +642.1% | -0.3 | Buy (25) | $344.15 +91% |
| DSGN | Design Therapeutics, Inc. | Leans up +3 medium | — | — | 2021-03-26 | $670M | $9.02 | -30.7% | — | 0.4 | Strong Buy (8) | $21.57 +139% |
| AIP | Arteris, Inc. | Up +6 medium | loss-making -44.8% revenue +22.3% heavily indebted | Improving confidence | 2021-10-27 | $962M | $16.50 | -30.5% | +38.5% | 2.5 | Strong Buy (7) | $33.00 +100% |
| AMBQ | Ambiq Micro, Inc. | Up +4 medium | loss-making -29.7% revenue -4.7% | Improving confidence | 2025-07-30 | $1.2B | $39.68 | -30.1% | +122.1% | 2.7 | Buy (7) | $66.71 +68% |
| ARM | Arm Holdings plc | Leans up +3 medium | profitable 17.1% revenue +22.8% heavily indebted | — | 2023-09-14 | $203.9B | $152.20 | -29.8% | +321.0% | -0.3 | Buy (43) | $272.43 +79% |
| FIGR | Figure Technology Solutions, Inc. | Up +9 strong | profitable 28.2% revenue +55.7% heavily indebted | Improving confidence | 2025-09-11 | $5.7B | $23.84 | -29.5% | -3.3% | 1.5 | Buy (10) | $47.20 +98% |
| SIND | Sinda Ltd. | Leans up +2 split | — | — | 2026-06-26 | $1.9B | $9.09 | -29.1% | -8.2% | 0.5 | Buy (6) | $18.40 +102% |
| MNR | Mach Natural Resources LP | Leans up +3 medium | profitable 20.7% revenue +21.2% liquidity 0.8 | Fell on sound metrics, Profitable but deeply down, Thin liquidity | 2023-10-25 | $1.5B | $7.95 | -28.8% | -45.3% | 0.3 | Strong Buy (9) | $16.29 +105% |
| BROS | Dutch Bros Inc. | Up +5 medium | profitable 5.1% revenue +27.9% heavily indebted | — | 2021-09-15 | $6.4B | $32.78 | -28.8% | +102.8% | -0.1 | Strong Buy (27) | $55.04 +68% |
| PICS | PicS N.V. | Up +11 strong | profitable 14.6% revenue +65.0% heavily indebted | Fell on sound metrics, Profitable but deeply down | 2026-01-29 | $962M | $5.02 | -27.4% | -61.3% | -0.4 | Strong Buy (9) | $16.76 +234% |
| BKV | BKV Corporation | Up +5 strong | profitable 16.2% revenue +41.6% heavily indebted | — | 2024-09-26 | $2.1B | $17.40 | -26.9% | +22.4% | 0.0 | Strong Buy (11) | $31.27 +80% |
| BTGO | Bitgo Holdings, Inc. | Up +7 medium | loss-making -0.5% heavily indebted | Fell, analysts held | 2026-01-22 | $496M | $3.35 | -25.8% | -75.8% | 0.0 | Strong Buy (12) | $9.54 +185% |
| STUB | StubHub Holdings, Inc. | Leans up +2 split | loss-making -22.3% revenue -1.4% liquidity 1.0 heavily indebted | Fell, analysts held, Thin liquidity, Improving confidence | 2025-09-17 | $2.0B | $4.54 | -25.4% | -77.8% | 1.4 | Buy (14) | $9.21 +103% |
| CSQR | Csquare, Inc. | Up +4 medium | loss-making -21.8% revenue +8.8% heavily indebted | Fell, analysts held | 2026-07-16 | $2.8B | $14.52 | -25.2% | -25.8% | 0.0 | Buy (10) | $27.90 +92% |
| APC | ARKO Petroleum Corp. | Leans up +3 split | profitable 0.7% revenue -12.3% heavily indebted | Shrinking revenue, Improving confidence | 2026-02-12 | $695M | $13.13 | -25.0% | -17.7% | 2.0 | Strong Buy (4) | $21.25 +62% |
| TYRA | Tyra Biosciences, Inc. | Up +4 medium | — | — | 2021-09-15 | $1.4B | $20.12 | -23.6% | +26.2% | -0.6 | Strong Buy (15) | $47.45 +136% |
| PBLS | Parabilis Medicines, Inc. | Up +4 medium | pre-revenue heavily indebted | — | 2026-06-10 | $3.6B | $27.44 | -23.6% | +35.8% | 0.0 | Strong Buy (7) | $41.00 +49% |
| BVS | Bioventus Inc. | Leans up +2 medium | profitable 9.8% revenue -0.9% heavily indebted | — | 2021-02-11 | $898M | $9.88 | -23.2% | — | 0.0 | Strong Buy (5) | $16.60 +68% |
| SKHY | SK hynix Inc. | Up +10 strong | profitable 70.1% revenue +46.8% heavily indebted | Improving confidence | 2026-07-10 | $663.0B | $103.57 | -23.1% | +2.6% | 1.0 | Strong Buy (15) | $259.50 +151% |
| GENB | Generate Biomedicines, Inc. | Up +5 medium | pre-revenue revenue +55.9% heavily indebted | — | 2026-02-27 | $1.6B | $9.54 | -23.1% | -23.7% | 0.0 | Strong Buy (5) | $26.25 +175% |
| GFS | GLOBALFOUNDRIES Inc. | Up +4 medium | profitable 2.8% revenue +0.6% heavily indebted | Improving confidence | 2021-10-28 | $23.1B | $35.56 | -22.4% | -4.5% | 1.7 | Buy (23) | $64.77 +82% |
| FIG | Figma, Inc. | Up +4 medium | loss-making -40.2% revenue +41.0% heavily indebted | Fell on sound metrics | 2025-07-31 | $10.4B | $15.77 | -22.2% | -30.4% | 0.7 | Buy (16) | $27.41 +74% |
| HAWK | HawkEye 360, Inc. | Up +5 medium | loss-making -14.3% revenue +162.6% heavily indebted | Lock-up expiry, Fell on sound metrics, Improving confidence, Large daily move | 2026-05-07 | $1.8B | $16.14 | -21.6% | -35.5% | 1.1 | Strong Buy (11) | $27.70 +72% |
| STDN | Standard Nuclear, Inc. | Leans up +2 medium | loss-making -210.5% | Fell, analysts held | 2026-07-16 | $1.7B | $8.14 | -20.7% | -31.5% | -0.4 | Strong Buy (9) | $16.88 +107% |
| ANL | Adlai Nortye Group Ltd. | Up +4 medium | heavily indebted | Fell, analysts held | 2023-09-29 | $683M | $8.55 | -20.5% | -58.0% | 0.0 | Strong Buy (7) | $29.50 +245% |
| HSAI | Hesai Group | Up +4 medium | profitable 8.9% revenue +45.8% heavily indebted | — | 2023-02-09 | $2.3B | $11.83 | -20.2% | -34.9% | -0.7 | Strong Buy (19) | $23.37 +98% |
| ETOR | eToro Group Ltd. | Leans up +3 medium | profitable 2.4% revenue +9.4% heavily indebted | Fell on sound metrics, Profitable but deeply down | 2025-05-14 | $1.8B | $18.56 | -20.0% | -57.5% | 0.0 | Buy (15) | $36.60 +97% |
| MAIR | Madison Air Solutions Corporation | Up +6 medium | profitable 6.7% revenue +34.1% heavily indebted | Lock-up expiry, Improving confidence | 2026-04-16 | $14.1B | $22.01 | -19.6% | -11.1% | 1.6 | Strong Buy (10) | $34.00 +54% |
| HOOD | Robinhood Markets, Inc. | Up +5 medium | profitable 39.0% revenue +51.6% heavily indebted | Improving confidence | 2021-07-29 | $70.1B | $62.17 | -19.1% | +112.3% | 1.0 | Buy (32) | $127.77 +106% |
| SSMR | Sunshine Silver Mining & Refining Company | Leans up +3 medium | pre-revenue | Lock-up expiry | 2026-06-04 | $1.9B | $10.45 | -18.8% | -19.7% | 0.7 | Buy (6) | $19.08 +83% |
| RIVN | Rivian Automotive, Inc. | Up +7 medium | loss-making -45.9% revenue +8.4% heavily indebted | Fell, analysts held, Upgrade, Improving confidence | 2021-11-10 | $17.8B | $10.33 | -18.1% | -84.9% | 1.1 | Buy (25) | $17.94 +74% |
| MBX | MBX Biosciences, Inc. | Up +7 medium | — | Improving confidence | 2024-09-13 | $2.8B | $49.55 | -18.0% | +270.4% | 1.3 | Strong Buy (12) | $95.09 +92% |
| CAVA | CAVA Group, Inc. | Leans up +3 medium | profitable 4.5% revenue +22.4% heavily indebted | Improving confidence | 2023-06-15 | $6.8B | $48.84 | -18.0% | +177.7% | 1.5 | Buy (27) | $75.42 +54% |
| COMP | Compass, Inc. | Leans up +3 medium | profitable 1.1% revenue +23.7% heavily indebted | — | 2021-04-01 | $7.8B | $9.64 | -17.6% | — | -0.4 | Buy (12) | $12.46 +29% |
| EROK | EagleRock Land, LLC | Up +4 strong | profitable 37.4% revenue +699.0% heavily indebted | Lock-up expiry | 2026-05-14 | $2.8B | $19.70 | -17.5% | +9.4% | 0.0 | Buy (6) | $27.33 +39% |
| BZ | Kanzhun Limited | Up +5 medium | profitable 52.9% revenue +12.4% | — | 2021-06-11 | $5.8B | $12.87 | -16.7% | — | -0.2 | Strong Buy (22) | $20.74 +61% |
| GMRS | GMR Solutions Inc. | Up +4 medium | profitable 3.8% revenue -4.0% heavily indebted | Lock-up expiry, Fell on sound metrics | 2026-05-13 | $1.0B | $10.12 | -16.6% | -31.3% | 0.0 | Buy (8) | $18.38 +82% |
| CRCL | Circle Internet Group, Inc. | Up +5 strong | profitable 15.3% revenue +63.9% | — | 2025-06-05 | $16.0B | $47.51 | -16.6% | +113.1% | 0.8 | Buy (29) | $102.37 +115% |
| RLX | RLX Technology Inc. | Up +6 strong | profitable 21.9% revenue +48.0% | — | 2021-01-22 | $1.9B | $1.40 | -16.6% | — | 0.3 | Strong Buy (6) | $2.78 +99% |
| Q | Qnity Electronics, Inc. | Up +6 strong | profitable 10.2% revenue +9.7% heavily indebted | — | 2025-10-27 | $24.7B | $103.47 | -15.9% | — | 0.4 | Strong Buy (10) | $173.30 +67% |
| VOR | Vor Biopharma Inc. | Leans up +2 split | — | — | 2021-02-05 | $1.2B | $19.19 | -15.6% | — | 0.2 | Strong Buy (10) | $39.00 +103% |
| IPSC | Century Therapeutics, Inc. | Leans up +2 split | heavily indebted | — | 2021-06-17 | $300M | $1.17 | -15.4% | — | 0.0 | Buy (5) | $4.75 +308% |
| COIN | Coinbase Global, Inc. | Leans up +2 medium | loss-making -12.5% revenue +9.4% heavily indebted | — | 2021-04-15 | $33.8B | $101.97 | -15.2% | — | 0.3 | Buy (37) | $195.00 +91% |
| AUNA | Auna S.A. | Up +5 strong | profitable 0.3% revenue -0.0% heavily indebted | Fell on sound metrics, Profitable but deeply down | 2024-03-22 | $340M | $3.66 | -14.7% | -63.2% | 0.0 | Buy (7) | $6.99 +91% |
| IMCR | Immunocore Holdings plc | Leans up +2 weak | loss-making -7.5% revenue +28.9% heavily indebted | — | 2021-02-05 | $1.5B | $26.41 | -14.6% | — | -1.2 | Buy (12) | $59.40 +125% |
| BLSM | BlossomHill Therapeutics, Inc. | Leans up +3 medium | heavily indebted | — | 2026-08-07 | $446M | $14.51 | -14.4% | -19.4% | 0.0 | Strong Buy (5) | $35.40 +144% |
| ERAS | Erasca, Inc. | Leans up +2 medium | heavily indebted | — | 2021-07-16 | $5.5B | $13.61 | -14.3% | -4.6% | 0.2 | Buy (9) | $24.11 +77% |
| RELY | Remitly Global, Inc. | Up +9 strong | profitable 19.1% revenue +29.4% heavily indebted | Fell on sound metrics, Profitable but deeply down | 2021-09-23 | $4.8B | $19.83 | -14.3% | -40.5% | 0.0 | Strong Buy (10) | $32.00 +61% |
| WBI | WaterBridge Infrastructure LLC | Up +7 strong | profitable 1.2% revenue +66.2% heavily indebted | Improving confidence | 2025-09-17 | $3.4B | $24.91 | -13.6% | +55.5% | 1.7 | Buy (8) | $36.75 +48% |
| TCBX | Third Coast Bancshares, Inc. | Up +4 medium | profitable 30.7% revenue +21.9% heavily indebted | Improving confidence | 2021-11-09 | $661M | $37.05 | -13.3% | +66.4% | 1.8 | Buy (7) | $47.36 +28% |
| CINT | CI&T Inc. | Up +7 strong | profitable 6.3% revenue +11.6% heavily indebted | Profitable but deeply down | 2021-11-10 | $390M | $2.68 | -13.3% | -79.5% | -1.0 | Buy (10) | $5.63 +110% |
| DC | Dakota Gold Corp. | Leans up +2 split | — | — | 2022-04-05 | $715M | $4.11 | -13.1% | — | 0.2 | Strong Buy (6) | $12.26 +198% |
| AFRM | Affirm Holdings, Inc. | Up +6 strong | profitable 43.9% revenue +32.1% heavily indebted | — | 2021-01-13 | $22.1B | $54.00 | -12.6% | — | 0.5 | Buy (36) | $95.81 +77% |
| MWH | SOLV Energy, Inc. | Up +4 medium | profitable 4.1% revenue +34.8% heavily indebted | — | 2026-02-11 | $5.6B | $24.69 | -11.8% | +4.1% | -0.9 | Strong Buy (11) | $40.55 +64% |
| JCAP | Jefferson Capital, Inc. | Up +5 strong | profitable 23.6% revenue +41.5% heavily indebted | Large daily move | 2025-06-26 | $1.2B | $20.72 | -11.7% | +42.4% | 0.0 | Buy (5) | $28.60 +38% |
| VERA | Vera Therapeutics, Inc. | Leans up +3 medium | pre-revenue heavily indebted | — | 2021-05-14 | $2.0B | $25.45 | -11.2% | — | -0.7 | Strong Buy (14) | $71.36 +180% |
| NU | Nu Holdings Ltd. | Up +6 strong | profitable 27.1% revenue +28.5% heavily indebted | Large daily move | 2021-12-09 | $64.0B | $11.27 | -10.3% | +41.9% | -1.1 | Buy (23) | $17.83 +58% |
| VIK | Viking Holdings Ltd | Up +5 split | profitable 18.6% revenue +21.9% liquidity 0.8 heavily indebted | Thin liquidity, Upgrade, Improving confidence | 2024-05-01 | $40.1B | $94.02 | -10.0% | +272.6% | 2.3 | Strong Buy (23) | $110.05 +17% |
| AVAH | Aveanna Healthcare Holdings Inc. | Leans up +3 medium | profitable 11.4% revenue +20.2% heavily indebted | Improving confidence | 2021-04-29 | $2.5B | $11.01 | -9.4% | — | 1.4 | Buy (11) | $15.20 +38% |
| KSPI | Joint Stock Company Kaspi.kz | Leans up +3 medium | profitable 24.3% revenue +59.8% heavily indebted | — | 2024-01-19 | $17.1B | $83.51 | -9.2% | -0.5% | 0.0 | Buy (7) | $106.52 +28% |
| NHP | National Healthcare Properties, Inc. | Leans up +3 strong | loss-making -3.4% revenue -3.2% heavily indebted | Lock-up expiry, Thin liquidity | 2026-04-22 | $1.1B | $14.82 | -9.2% | +24.1% | 0.6 | Buy (8) | $19.57 +32% |
| MH | McGraw Hill, Inc. | Up +5 medium | profitable 3.5% revenue +0.1% liquidity 0.9 heavily indebted | Thin liquidity | 2025-07-24 | $2.2B | $12.05 | -9.2% | -19.7% | 0.0 | Strong Buy (13) | $17.33 +44% |
| FLOC | Flowco Holdings Inc. | Up +5 strong | profitable 6.4% revenue +41.9% heavily indebted | — | 2025-01-16 | $1.9B | $18.94 | -9.1% | -15.1% | -0.9 | Buy (9) | $29.78 +57% |
| ABSI | Absci Corporation | Leans up +3 split | pre-revenue | Fell, analysts held, Shrinking revenue, Large daily move | 2021-07-22 | $1.5B | $7.51 | -8.6% | -49.7% | 0.6 | Strong Buy (12) | $15.09 +101% |
| TUYA | Tuya Inc. | Leans up +3 medium | profitable 20.2% revenue +7.8% | — | 2021-03-18 | $999M | $1.46 | -8.4% | — | -0.3 | Strong Buy (4) | $3.17 +117% |
| ZBIO | Zenas BioPharma, Inc. | Up +4 medium | pre-revenue revenue +100.0% | — | 2024-09-13 | $1.9B | $23.85 | -8.2% | +61.0% | 0.0 | Strong Buy (8) | $47.88 +101% |
| AS | Amer Sports, Inc. | Up +5 medium | profitable 8.2% revenue +26.7% heavily indebted | — | 2024-02-01 | $17.4B | $28.27 | -8.1% | +124.5% | -0.2 | Strong Buy (27) | $47.47 +68% |
| LB | LandBridge Corporation | Leans up +3 medium | profitable 17.1% revenue +81.1% heavily indebted | — | 2024-06-28 | $5.6B | $70.39 | -8.0% | +424.8% | 0.0 | Buy (7) | $89.57 +27% |
| ARXS | Arxis, Inc. | Up +6 strong | profitable 6.5% revenue +115.5% heavily indebted | Lock-up expiry | 2026-04-16 | $23.0B | $48.46 | -7.5% | +93.4% | 0.5 | Strong Buy (11) | $66.50 +37% |
| AURA | Aura Biosciences, Inc. | Leans up +3 medium | heavily indebted | Fell, analysts held | 2021-10-29 | $740M | $6.87 | -7.4% | -53.3% | 0.0 | Strong Buy (6) | $16.60 +142% |
| FLY | Firefly Aerospace Inc. | Leans up +3 medium | loss-making -88.4% revenue +162.9% heavily indebted | Fell on sound metrics | 2025-08-07 | $4.3B | $17.69 | -7.2% | -56.0% | 0.3 | Buy (11) | $36.64 +107% |
| LBRX | LB Pharmaceuticals Inc | Up +4 medium | — | — | 2025-09-11 | $1.4B | $38.85 | -7.0% | +166.5% | -1.0 | Strong Buy (11) | $58.00 +49% |
| SUNS | Sunrise Realty Trust, Inc. | Leans up +2 medium | profitable 34.9% revenue +143.2% heavily indebted | — | 2024-07-09 | $98M | $6.41 | -7.0% | — | 0.0 | Buy (4) | $10.13 +58% |
| SMWB | Similarweb Ltd. | Up +4 medium | loss-making -4.6% revenue +13.1% liquidity 0.8 heavily indebted | Thin liquidity, Improving confidence | 2021-05-12 | $703M | $7.74 | -6.9% | — | 1.1 | Buy (8) | $10.83 +40% |
| TPG | TPG Inc. | Leans up +2 medium | profitable 7.5% revenue +27.0% heavily indebted | — | 2022-01-13 | $18.6B | $44.32 | -6.8% | +69.5% | 0.6 | Buy (17) | $59.53 +34% |
| VINP | Vinci Compass Investments Ltd. | Up +5 strong | profitable 30.1% revenue +62.7% heavily indebted | — | 2021-01-28 | $577M | $8.01 | -6.7% | — | 0.0 | Buy (6) | $12.63 +58% |
| INR | Infinity Natural Resources, Inc. | Leans up +3 medium | profitable 7.9% revenue +37.6% liquidity 0.7 heavily indebted | Thin liquidity | 2025-01-31 | $821M | $10.92 | -6.6% | -29.3% | -0.6 | Strong Buy (9) | $21.11 +93% |
| TTAN | ServiceTitan, Inc. | Up +4 medium | loss-making -12.1% revenue +24.5% heavily indebted | — | 2024-12-12 | $8.0B | $76.23 | -6.5% | +18.0% | 0.0 | Buy (18) | $96.81 +27% |
| BBNX | Beta Bionics, Inc. | Leans up +3 medium | loss-making -65.3% revenue +53.9% | — | 2025-01-30 | $893M | $13.36 | -6.5% | -2.2% | -0.2 | Buy (15) | $25.10 +88% |
| PHVS | Pharvaris N.V. | Leans up +3 medium | — | — | 2021-02-05 | $2.3B | $31.28 | -5.5% | — | 0.9 | Strong Buy (14) | $58.16 +86% |
| DSP | Viant Technology Inc. | Leans up +3 medium | profitable 1.9% revenue +19.0% heavily indebted | — | 2021-02-10 | $781M | $10.07 | -5.5% | — | 0.0 | Strong Buy (11) | $19.32 +92% |
| FSBC | Five Star Bancorp | Up +5 medium | profitable 41.3% revenue +25.7% heavily indebted | — | 2021-05-05 | $1.1B | $40.99 | -5.4% | — | 0.0 | Buy (5) | $51.40 +25% |
| LIFE | Ethos Technologies Inc. | Up +4 medium | loss-making -16.2% revenue +52.0% | — | 2026-01-29 | $2.2B | $31.22 | -5.4% | +122.7% | -0.6 | Strong Buy (9) | $53.38 +71% |
| SPCX | Space Exploration Technologies Corp. | Up +8 strong | loss-making -8.6% revenue +33.2% heavily indebted | Improving confidence | 2026-06-12 | $1.89T | $127.79 | -4.9% | +4.7% | 1.5 | Buy (40) | $255.63 +100% |
| ALH | Alliance Laundry Holdings Inc. | Leans up +2 medium | profitable 11.7% heavily indebted | — | 2025-10-09 | $4.6B | $24.27 | -4.7% | +7.0% | 0.0 | Strong Buy (8) | $31.00 +28% |
| VG | Venture Global, Inc. | Leans up +3 medium | profitable 31.1% revenue +176.9% liquidity 0.9 heavily indebted | Profitable but deeply down, Thin liquidity, Improving confidence | 2025-01-24 | $33.1B | $11.95 | -4.4% | -41.3% | 1.6 | Buy (17) | $17.56 +47% |
| PAYP | PayPay Corporation | Up +9 strong | profitable 16.3% revenue +25.9% heavily indebted | — | 2026-03-12 | $9.7B | $11.67 | -4.1% | -13.1% | 0.8 | Strong Buy (13) | $23.67 +103% |
| ALMR | Alamar Biosciences, Inc. | Up +4 strong | loss-making -48.2% revenue +195.2% heavily indebted | Lock-up expiry | 2026-04-17 | $2.1B | $26.48 | -4.1% | +87.0% | 0.0 | Buy (5) | $37.00 +40% |
| NXT | Nextpower Inc. | Up +6 medium | profitable 16.0% revenue +20.3% | Improving confidence | 2023-02-09 | $14.3B | $67.13 | -4.1% | +244.0% | 1.4 | Strong Buy (30) | $127.90 +91% |
| FVR | FrontView REIT, Inc. | Leans up +3 medium | loss-making -0.0% revenue +341.0% heavily indebted | Thin liquidity | 2024-10-02 | $583M | $17.97 | -4.1% | -2.7% | 0.7 | Buy (11) | $21.64 +20% |
| LOAR | Loar Holdings Inc. | Up +4 strong | profitable 9.4% revenue +23.2% heavily indebted | — | 2024-04-25 | $7.0B | $63.64 | -3.9% | +140.8% | -1.0 | Buy (5) | $88.80 +40% |
| COCO | The Vita Coco Company, Inc. | Up +4 medium | profitable 15.7% revenue +18.2% heavily indebted | — | 2021-10-21 | $3.6B | $64.37 | -3.6% | +292.2% | 0.3 | Buy (12) | $79.10 +23% |
| SEPN | Septerna, Inc. | Leans up +2 medium | loss-making -61.3% revenue +4174.5% heavily indebted | — | 2024-10-25 | $2.0B | $38.61 | -3.6% | +109.3% | 0.1 | Strong Buy (10) | $59.22 +53% |
| CGON | CG Oncology, Inc. | Up +5 strong | pre-revenue | — | 2024-01-25 | $6.6B | $79.47 | -3.5% | +219.3% | -0.8 | Strong Buy (14) | $92.15 +16% |
| SGMT | Sagimet Biosciences Inc. | Up +4 medium | — | — | 2023-07-14 | $729M | $9.08 | -2.0% | -37.2% | -1.0 | Buy (12) | $27.27 +200% |
| FRBT | Forbright, Inc. | Up +6 strong | profitable 20.4% revenue +29.5% heavily indebted | — | 2026-06-11 | $951M | $16.70 | -1.9% | +2.5% | 0.8 | Buy (6) | $23.25 +39% |
| YMM | Full Truck Alliance Co. Ltd. | Up +8 strong | profitable 35.9% revenue +11.1% | Fell on sound metrics, Profitable but deeply down | 2021-06-22 | $9.0B | $8.82 | -1.7% | -56.5% | 0.6 | Buy (15) | $12.51 +42% |
| VNOM | Viper Energy, Inc. | Up +5 medium | profitable 12.1% revenue +62.1% heavily indebted | — | 2025-08-19 | $15.3B | $39.69 | -1.6% | — | -0.6 | Strong Buy (20) | $55.45 +40% |
| DLO | DLocal Limited | Up +7 strong | profitable 14.9% revenue +46.6% heavily indebted | Improving confidence | 2021-06-03 | $3.9B | $12.04 | -1.6% | — | 1.0 | Buy (10) | $18.50 +54% |
| PTRN | Pattern Group Inc. | Up +7 strong | profitable 3.6% revenue +39.3% heavily indebted | Upgrade | 2025-09-19 | $3.6B | $18.51 | -1.4% | +32.4% | -0.1 | Strong Buy (9) | $27.88 +51% |
| TRIN | Trinity Capital Inc. | Leans up +2 weak | profitable 67.4% revenue +16.6% heavily indebted | — | 2021-01-29 | $1.7B | $16.63 | -1.2% | — | 0.0 | Buy (9) | $19.00 +14% |
| TWFG | TWFG, Inc. | Leans up +2 medium | profitable 2.8% revenue +20.8% heavily indebted | — | 2024-07-18 | $1.4B | $25.66 | -1.1% | +54.4% | 0.6 | Buy (8) | $31.71 +24% |
| YSWY | Yesway, Inc. | Up +5 strong | profitable 1.1% revenue +5.8% heavily indebted | Lock-up expiry | 2026-04-22 | $1.6B | $20.11 | -0.8% | +27.4% | 0.6 | Buy (9) | $29.63 +47% |
| WHK | WhiteHawk Minerals Corp. | Up +5 strong | loss-making -78.4% revenue +427.7% heavily indebted | — | 2026-06-09 | $791M | $23.88 | -0.5% | +2.2% | 0.0 | Strong Buy (5) | $32.40 +36% |
Showing 145 of 477 tracked IPOs. Our balance, the flags, the fundamentals and the analyst figures come from the weekly run of 2026-11-17. Prices are refreshed daily and were last taken on 2026-11-20; a thinly traded company shows its most recent trade, which may be older. Use the filters to narrow the list, or click a column heading to sort.
The three-month window is deliberate. A week is noise and a year buries the move in the IPO itself; three months is long enough for a repricing and short enough that the published views have had time to react and have not. Where a company carries a Lock-up expiry flag, part of the fall may be supply rather than sentiment — the dates are on the Key Dates page, with how many normal trading sessions the unlocking stock would take to absorb.
How to read this. Our score runs from −10 to +10 and is computed here from the filings and the price history, not copied from anyone — the Scores page sets out what goes into it and Method says where every figure comes from. Our view is the direction that score leans, in words. Consensus is the analyst consensus with the number of analysts behind it in brackets; a consensus resting on four or five people is not the same object as one resting on thirty, which is why the count is always shown. Implied upside is the consensus target against the latest close. The 3-month change is highlighted where the move is 40% or more in either direction. Of the 470 listed IPOs we track, 105 are left out of both screens before anything is ranked: 9 are under a takeover offer, 32 carry no consensus target at all, 36 are followed by fewer than four analysts, 7 trade below a dollar, and 21 show an implied upside above 300%, counting each by the first test it fails. Two of those deserve a word. A target three times the share price is almost always a target nobody has revised, not a bullish call. And a company under a takeover offer is not a disagreement at all: the price tracks the bid and the rating goes to hold, which is the mechanism working, not a gap between the market and the page. A disagreement is not a forecast and not a recommendation: it says the price and the published view have moved apart, and gives you the pieces to work out which one you find more convincing. Nothing on this page is a recommendation to buy or sell.
